Signal Genetics Inc Stock Nasdaq
Stocks
US8266401046
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 2.07B 1.82B 1.68B 1.56B 2.95B 196B 3B 20.11B 7.81B 96.81B 7.8B 7.62B 337B | P/E 2026 * |
-4.9x | P/E 2027 * | -7.99x |
|---|---|---|---|---|---|
| Enterprise Value | 1.34B 1.18B 1.08B 1.01B 1.91B 127B 1.94B 13.01B 5.05B 62.65B 5.04B 4.93B 218B | EV / Sales 2026 * |
46.8x | EV / Sales 2027 * | 6.01x |
| Free-Float |
98.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Signal Genetics Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Mahoney
CEO | Chief Executive Officer | 55 | 30/10/2023 |
Seth Harmon
DFI | Director of Finance/CFO | 46 | 12/09/2023 |
Kirk Bertelsen
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 74 | 03/01/2018 |
Tomas Kiselak
CHM | Chairman | 39 | 01/06/2021 |
Jennifer Moses
BRD | Director/Board Member | 51 | 14/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.15% | +5.94% | -3.40% | +2.32% | 46.62B | |
| -3.69% | +9.30% | +403.59% | +592.60% | 40.95B | |
| +0.08% | +12.86% | +22.67% | -14.00% | 32.26B | |
| -1.65% | +3.30% | +17.84% | +59.98% | 32.24B | |
| -3.29% | +2.85% | +13.80% | +30.30% | 25.53B | |
| +0.99% | +12.02% | - | - | 16.38B | |
| -0.85% | +12.26% | +69.35% | +121.31% | 15.27B | |
| +0.56% | +8.00% | +12.65% | +21.35% | 13.61B | |
| -1.34% | +4.47% | +100.94% | +93.49% | 13.34B | |
| Average | -0.86% | +10.33% | +79.68% | +113.42% | 26.24B | |
| Weighted average by Cap. | -0.96% | +10.36% | +93.74% | +136.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.67M 25.09M 23.17M 21.61M 40.71M 2.71B 41.44M 278M 108M 1.34B 108M 105M 4.66B | 251M 220M 203M 189M 356M 23.71B 362M 2.43B 944M 11.7B 942M 921M 40.76B |
| Net income | -442M -387M -357M -333M -628M -41.78B -639M -4.28B -1.66B -20.62B -1.66B -1.62B -71.83B | -291M -255M -235M -219M -413M -27.5B -420M -2.82B -1.09B -13.57B -1.09B -1.07B -47.27B |
| Net Debt | -732M -641M -592M -552M -1.04B -69.23B -1.06B -7.1B -2.75B -34.16B -2.75B -2.69B -119B | -567M -496M -458M -427M -805M -53.59B -819M -5.49B -2.13B -26.44B -2.13B -2.08B -92.12B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
